Deepu David1, Anantharam Raghavendran2, Ashish Goel3, C Bharath Kumar4, Thomas Alex Kodiatte5, Deepak Burad5, Priya Abraham2, Banumathi Ramakrishna5, Philip Joseph6, Jeyamani Ramachandran3, C E Eapen3. 1. Department of Gastroenterology, Division of Gastrointestinal Sciences, Christian Medical College and Hospital, Vellore, 632 004, India. deepudavid@gmail.com. 2. Department of Virology, Christian Medical College and Hospital, Vellore, 632 004, India. 3. Department of Hepatology, Christian Medical College and Hospital, Vellore, 632 004, India. 4. Department of Gastroenterology, Division of Gastrointestinal Sciences, Christian Medical College and Hospital, Vellore, 632 004, India. 5. Department of Pathology, Christian Medical College and Hospital, Vellore, 632 004, India. 6. Department of Surgery, Christian Medical College and Hospital, Vellore, 632 004, India.
Abstract
AIM OF THE STUDY: The aim of the study was to analyze the prevalence of risk factors for non-alcoholic fatty liver disease (NAFLD) in patients with non-B non-C hepatocellular carcinoma (HCC). METHODS: Between June 2012 and November 2014, patients with HCC, negative for hepatitis B surface antigen and hepatitis C virus antibody, were included in this study. All patients were assessed for risk factors for NAFLD such as diabetes mellitus (DM), hypertension, dyslipidemia, metabolic syndrome, and obesity. RESULTS: Forty-seven patients with non-B non-C HCC (males, 37; age, 60±10 years; mean±SD) were studied. Model for end-stage liver disease score was 11±4. Twenty-five patients were in Child's class A. History of significant alcohol intake was noted in 11 (23%) patients. Prevalence of risk factors for NAFLD were obesity 24 (51%), DM 22 (47%), metabolic syndrome 21 (45%), hypertension 16 (34%), and dyslipidemia 13 (28%). Forty (85%) patients had at least one risk factor for NAFLD. The mean duration of at least one NAFLD risk factor was 7.5 years, prior to diagnosis of HCC. Thirteen (28%) patients were positive for anti-HBc; however, none of the study patients had detectable HBV DNA in blood. CONCLUSIONS: Eighty-five percent of the patients with non-B non-C HCC had at least one risk factor for NAFLD. None of the study patients had occult hepatitis B infection. NAFLD is emerging as the major etiological contributing factor for non-B non-C HCC in India.
AIM OF THE STUDY: The aim of the study was to analyze the prevalence of risk factors for non-alcoholic fatty liver disease (NAFLD) in patients with non-B non-C hepatocellular carcinoma (HCC). METHODS: Between June 2012 and November 2014, patients with HCC, negative for hepatitis B surface antigen and hepatitis C virus antibody, were included in this study. All patients were assessed for risk factors for NAFLD such as diabetes mellitus (DM), hypertension, dyslipidemia, metabolic syndrome, and obesity. RESULTS: Forty-seven patients with non-B non-C HCC (males, 37; age, 60±10 years; mean±SD) were studied. Model for end-stage liver disease score was 11±4. Twenty-five patients were in Child's class A. History of significant alcohol intake was noted in 11 (23%) patients. Prevalence of risk factors for NAFLD were obesity 24 (51%), DM 22 (47%), metabolic syndrome 21 (45%), hypertension 16 (34%), and dyslipidemia 13 (28%). Forty (85%) patients had at least one risk factor for NAFLD. The mean duration of at least one NAFLD risk factor was 7.5 years, prior to diagnosis of HCC. Thirteen (28%) patients were positive for anti-HBc; however, none of the study patients had detectable HBV DNA in blood. CONCLUSIONS: Eighty-five percent of the patients with non-B non-C HCC had at least one risk factor for NAFLD. None of the study patients had occult hepatitis B infection. NAFLD is emerging as the major etiological contributing factor for non-B non-C HCC in India.
Entities:
Keywords:
Hepatocellular carcinoma; NAFLD; Non-B non-C HCC; Occult hepatitis B
Authors: S K Sarin; V Thakur; R C Guptan; S Saigal; V Malhotra; S P Thyagarajan; B C Das Journal: J Gastroenterol Hepatol Date: 2001-06 Impact factor: 4.029
Authors: Sandip Pal; Jeyamani Ramachandran; Reuben Thomas Kurien; Anu Eapen; Banumathi Ramakrishna; Shyamkumar N Keshava; Ashish Goel; K G Sajith; C E Eapen Journal: Trop Doct Date: 2013-02-26 Impact factor: 0.731
Authors: Min Ju Kim; Oh Sang Kwon; Nak So Chung; Seo Young Lee; Hyuk Sang Jung; Dong Kyun Park; Yang Suh Ku; Yu Kyung Kim; Yun Soo Kim; Ju Hyun Kim Journal: Korean J Hepatol Date: 2008-03